Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03047473
Title Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme (SEJ)
Acronym SEJ
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Clinique Neuro-Outaouais
Indications
Therapies
Age Groups: senior | adult
Covered Countries CAN


No variant requirements are available.